Basic Information
Basic information for MIR4300HG-213-29aa
Peptide Name MIR4300HG-213-29aa
Genome Position chr11:81879895-81879981[-]
Species Human
Peptide Sequence MRLGYKRLRLPCFHLGLCLSENSHVNDSS
Peptide Length 29
Unique No (MIR4300HG-201-29aa,MIR4300HG-202-29aa,MIR4300HG-205-29aa,MIR4300HG-209-29aa,MIR4300HG-210-29aa)
Grand Average of Hydropathicity -0.2759
Relative Molecular Mass 3851.29
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000245832;MIR4300HG
Transcript ID/Name ENST00000671244;MIR4300HG-213
Transcript Length 1047
Coding Ability 0.3973
DNA Sequence Corresponding to Peptide ATGAGATTAGGGTATAAAAGACTAAGGCTTCCATGCTTCCATCTTGGTCTCTGTCTCTCAGAGAACAGTCATGTGAATGATTCTTCT
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :